Terms: = Breast cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Diagnosis
54 results:
1. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
[TBL] [Abstract] [Full Text] [Related]
2. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
3. Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective.
Molina-Zayas M; Garrido-Navas C; García-Puche JL; Barwell J; Pedrinaci S; Atienza MM; García-Linares S; de Haro-Muñoz T; Lorente JA; Serrano MJ; Poyatos-Andújar A
Mol Genet Genomics; 2022 May; 297(3):859-871. PubMed ID: 35451682
[TBL] [Abstract] [Full Text] [Related]
4. Early age of onset and broad cancer spectrum persist in msh6- and PMS2-associated Lynch syndrome.
Liu YL; Cadoo KA; Maio A; Patel Z; Kemel Y; Salo-Mullen E; Catchings A; Ranganathan M; Kane S; Soslow R; Ceyhan-Birsoy O; Mandelker D; Carlo MI; Walsh MF; Shia J; Markowitz AJ; Offit K; Stadler ZK; Latham A
Genet Med; 2022 Jun; 24(6):1187-1195. PubMed ID: 35346574
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ
Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721
[TBL] [Abstract] [Full Text] [Related]
6. Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer.
Ren M; Orozco A; Shao K; Albanez A; Ortiz J; Cao B; Wang L; Barreda L; Alvarez CS; Garland L; Wu D; Chung CC; Wang J; Frone M; Ralon S; Argueta V; Orozco R; Gharzouzi E; Dean M
Breast Cancer Res Treat; 2021 Sep; 189(2):533-539. PubMed ID: 34196900
[TBL] [Abstract] [Full Text] [Related]
7. Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
Laish I; Friedman E; Levi-Reznick G; Kedar I; Katz L; Levi Z; Halpern N; Parnasa S; Abu-Shatya A; Half E; Goldberg Y
Breast Cancer Res Treat; 2021 Aug; 188(3):685-694. PubMed ID: 34086170
[TBL] [Abstract] [Full Text] [Related]
8. The contribution of Lynch syndrome to early onset malignancy in Ireland.
Talbot A; O'Donovan E; Berkley E; Nolan C; Clarke R; Gallagher D
BMC Cancer; 2021 May; 21(1):617. PubMed ID: 34039291
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
[TBL] [Abstract] [Full Text] [Related]
10. Multigene assessment of genetic risk for women for two or more breast cancers.
Weitzel JN; Kidd J; Bernhisel R; Shehayeb S; Frankel P; Blazer KR; Turco D; Nehoray B; McGreevy K; Svirsky K; Brown K; Gardiner A; Daly M; Hughes E; Cummings S; Saam J; Slavin TP
Breast Cancer Res Treat; 2021 Aug; 188(3):759-768. PubMed ID: 33826040
[TBL] [Abstract] [Full Text] [Related]
11. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract] [Full Text] [Related]
12. Predicted Chemotherapy Benefit for breast cancer Patients With Germline Pathogenic Variants in cancer Susceptibility Genes.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
[TBL] [Abstract] [Full Text] [Related]
13. Easy One-Step Amplification and Labeling Procedure for Copy Number Variation Detection.
Blesa S; Olivares MD; Alic AS; Serrano A; Lendinez V; González-Albert V; Olivares L; Martínez-Hervás S; Juanes JM; Marín P; Real JT; Navarro B; García-García AB; Chaves FJ; Ivorra C
Clin Chem; 2020 Mar; 66(3):463-473. PubMed ID: 32068788
[TBL] [Abstract] [Full Text] [Related]
14. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract] [Full Text] [Related]
15. Multigene panel testing results in patients with multiple breast cancer primaries.
Corredor J; Woodson AH; Gutierrez Barrera A; Arun B
Breast J; 2020 Jul; 26(7):1337-1342. PubMed ID: 31999039
[TBL] [Abstract] [Full Text] [Related]
16. Malignant phyllodes tumor in Lynch syndrome: a case report.
Kazmi S; Wagner S; Heintzelman R; Corbman M
J Med Case Rep; 2019 Jul; 13(1):216. PubMed ID: 31307558
[TBL] [Abstract] [Full Text] [Related]
17. New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients.
Gervas P; Klyuch B; Denisov E; Kiselev A; Molokov A; Pisareva L; Malinovskaya E; Choynzonov E; Cherdyntseva N
Mol Biol Rep; 2019 Oct; 46(5):5537-5541. PubMed ID: 31273614
[TBL] [Abstract] [Full Text] [Related]
18. Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes.
Tian W; Bi R; Ren Y; He H; Shi S; Shan B; Yang W; Wang Q; Wang H
Int J Cancer; 2019 Sep; 145(5):1290-1298. PubMed ID: 31054147
[TBL] [Abstract] [Full Text] [Related]
19. Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
Bernstein-Molho R; Singer A; Laitman Y; Netzer I; Zalmanoviz S; Friedman E
Breast Cancer Res Treat; 2019 Jul; 176(1):165-170. PubMed ID: 30980208
[TBL] [Abstract] [Full Text] [Related]
20. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
[TBL] [Abstract] [Full Text] [Related]
[Next]
